Refined pseudo-germ-free mice reveal gut microbes' role in pancreatic cancer

Article excerpt

Researchers at National Taiwan University developed a safer mouse model to study how gut bacteria influence pancreatic cancer. Rather than completely sterilizing mice, which damages their health, they created a "pseudo-germ-free" variant that allows controlled bacterial manipulation. The refined approach revealed a striking finding: when antibiotics altered the mice's gut microbiome, tumors shrank and chemotherapy became more effective. The discovery suggests the gut microbiome may be a lever for improving cancer treatment, opening a new angle for clinical research beyond genetic or immunological approaches.